Table 2.
Cross-Method Agreement of Self-Reported Adherence With Electronic Monitoring Over Time (n = 180)
| Oral Hypoglycemic Agent | Electronic Monitoring Adherence
|
Self-Reported Adherence
|
Adherence Agreement
|
|
|---|---|---|---|---|
| Kappa Coefficient
| ||||
| n (%) | n (%) | Kappa | P | |
| Baseline | 77 (42.8%) | 146 (81.1%) | 0.133 | .012 |
|
| ||||
| 6 weeks | 112 (62.2%) | 137 (76.1%) | 0.147 | .038 |
|
| ||||
| 12 weeks | 118 (65.6%) | 131 (72.8%) | 0.210 | .004 |
|
| ||||
| Antidepressants | ||||
|
| ||||
| Baseline | 69 (38.3%) | 133 (73.9%) | 0.180 | .002 |
|
| ||||
| 6 weeks | 104 (57.8%) | 136 (75.6%) | 0.179 | .009 |
|
| ||||
| 12 weeks | 105 (58.3%) | 127 (70.6%) | 0.380 | <.001 |
Adherence was operationalized as ≥80% adherence. n = number of participants who were adherent by method of adherence.